Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (5)
  1. 2. Kemlin, D., Lemy, A., Pannus, P., Desombere, I., Gemander, N., Goossens, M. M., Marchant, A., & Le Moine, A. (2021). Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients. American Journal of Transplantation. doi:10.1111/ajt.16853
  2. 3. Gantt, S., Marchant, A., & Boppana, S. S. (2018). Higher expectations for a vaccine to prevent congenital cytomegalovirus infection. Journal of virology, 92(15), e00764-18. doi:10.1128/JVI.00764-18
  3. 4. Molès, J. P., Tuaillon, E., Kankasa, C., Bedin, A. S., Nagot, N., Marchant, A., McDermid, J. J., & Van de Perre, P. (2017). Breastfeeding-related maternal microchimerism. Nature reviews. Immunology, 17(11), 729. doi:10.1038/nri.2017.115
  4. 5. Fish, E. E., Netea, M. G. H. M., Plebanski, M., Rowland-Jones, S., Selin, L. L., Shann, F., Whittle, H. H., Flanagan, K. L., Furman, D., Klein, S. S., Kollmann, T., Jeppesen, D. D., Levy, O., Marchant, A., & Namachivayam, S. (2016). Changing oral vaccine to inactivated polio vaccine might increase mortality. Lancet, 387(10023), 1054-1055. doi:10.1016/S0140-6736(16)00661-9
    5.   Participations à des congrès et colloques internationaux (11)
  5. 1. Helali, Y., Bourez, A., Marchant, A., Van Antwerpen, P., & Delporte, C. (2023). N-Glycosylation a biomarker to predict the death risk of patients in intensive care unit. Poster présenté à la conférence Annual meeting Society of Glycobiology (5-8/11/2023: Hawaii, USA).
  6. 2. Helali, Y., Bourez, A., Marchant, A., Van Antwerpen, P., & Delporte, C. (2023). NEW APPROACH USING ON LINE PURIFICATION AND PROCAINAMIDE FOR HILIC FLR MS N GLYCAN ANALYSIS. Poster présenté à la conférence GlycoBioTech 2023 (01/2023: Berlin).
  7. 3. Helali, Y., Bourez, A., Marchant, A., Van Antwerpen, P., & Delporte, C. (2022). NEW APPROACH USING ON-LINE PURIFICATION AND PROCAINAMIDE FOR HILIC-FLR-MS N-GLYCAN ANALYSIS. Poster présenté à la conférence 38th International Symposium on nMicroscale Sparations and Bioanalysis (MSB° (3-6-2022: Liège).
  8. 4. Maertens, K., De Brabandere, L., De Weerdt, L. L., Tommelein, E., Vercoutere, A., Dauby, N., Ariën, K., Desombere, I., Marchant, A., & Leuridan, E. (2021). Immune responses to different COVID-19 vaccine platforms in pregnancy. Poster présenté à la conférence Keystone Symposium. Maternal-Fetal Newborn Immunity (28-29/10/2021: Virtual).
  9. 5. Helali, Y., Marchant, A., Van Antwerpen, P., & Delporte, C. (2020). Rapid sample preparation for the profiling of N-glycans by liquid chromatography mass spectrometry and fluorescence detection (LC-MS-FLD). Poster présenté à la conférence Join us at the 36th International Symposium on Microscale Separations and Bioanalysis (Saint Malo (En ligne)).
  10. 6. Taton, M., Konopnicki, D., Cogan, A., Martin, C., Goetghebuer, T., De Wit, S., Marchant, A., Willems, F., & Dauby, N. (2019). IMPACT OF HIV INFECTION ON ANTIBODY AND MEMORY B CELL RESPONSES TO TDAP IMMUNIZATION DURING PREGNANCY. Poster présenté à la conférence 12th International Bordetella Symposium (09-04-2019: Brussels).
  11. 7. Costa, E., Delforge, M.-L., Zaytouni, S., Goldman, D., Montesinos Hernandez, I., Marchant, A., & donner, C. (2017). Association between Cytomegalovirus viral load in fetal blood and antenatal imaging anomalies: E. Costa, M-L Delforge, S. Zaytouni , D Goldman , I Montesinos , A Marchant, C Donner. Poster présenté à la conférence 6th international congenital CMV conference.
  12. 8. Costa, E., Delforge, M.-L., Brancart, F., Goldman, D., Montesinos Hernandez, I., Zaytouni, S., Marchant, A., & donner, C. (2016). Presence of Cytomegalovirus in urine and blood of pregnant women might be associated with infection in Offspring. Paper session presented at European Congenital Cytomegalovirus Initiative.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>